Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Endocrine 2Dermatologic 1

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Carcinoma, Hepatocellular 2Vipoma 1Uveal Melanoma 1Stomach Neoplasms 1Somatostatinoma 1Pheochromocytoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Insulinoma 1Glucagonoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Medullary 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adenoma, Islet Cell 1Adenocarcinoma Of Esophagus 1

Interventions

selpercatinib 3Trastuzumab 2Oxaliplatin 2Melphalan 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1sargramostim 1repotrectinib 1pralsetinib 1mercaptoundecahydrododecaborate 1entinostat 1aldesleukin 1Suramin 1Rose Bengal 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Patient Navigation 1Paclitaxel 1Molecular Diagnostic Techniques 1Microscopy, Electron 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Floxuridine 1Fentanyl 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Melphalan × Endocrine × Clear all
NCT00096083 2013-10-23

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Delcath Systems Inc.

Phase 2 Completed
56 enrolled
DermatologicEndocrineGastrointestinal

Adenocarcinoma Of Esophagus, Uveal Melanoma, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Melanoma, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Rectal Neoplasms, Somatostatinoma, Stomach Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
67 enrolled
EndocrineGastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡